Request Demo
Last update 12 Jul 2025
FC084CSA
Last update 12 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms FC084 Camphor Sulfonate, FC084樟脑磺酸盐, FC084CSA |
Target |
Action inhibitors |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with FC084CSANCT06499350
A Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of AXL Inhibitor FC084CSA Tablets in Combination With Tislelizumab in the Treatment of Advanced Malignant Solid Tumors
NCT06231550
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors
ChiCTR2300068597
A PhaseIClinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of Axl Inhibitor FC084CSA Tablets in Patients With Advanced Malignant Solid Tumors
100 Clinical Results associated with FC084CSA
Login to view more data
100 Translational Medicine associated with FC084CSA
Login to view more data
100 Patents (Medical) associated with FC084CSA
Login to view more data
100 Deals associated with FC084CSA
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 10 Nov 2024 | |
| Breast Cancer | IND Approval | China | 27 Oct 2022 | |
| Liver Cancer | IND Approval | China | 27 Oct 2022 | |
| Non-Small Cell Lung Cancer | IND Approval | China | 27 Oct 2022 | |
| Sarcoma | IND Approval | China | 27 Oct 2022 | |
| Stomach Cancer | IND Approval | China | 27 Oct 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free